B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

TYR

MOLECULAR TARGET

tyrosinase

UniProt: P14679NCBI Gene: 729925 compounds

TYR (tyrosinase) is targeted by 25 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting TYR

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1kojic acid5.27194
2Butylated Hydroxytoluene4.93137
3coumaric acid4.4282
4paraben4.1764
5hydroquinone3.9551
6e3193.8546
7oxyresveratrol3.0420
83 hydroxycoumarin2.9418
9hinokitiol2.8917
10methyl p hydroxycinnamate2.7715
11glabridin2.7114
12xanthone2.6413
13moracin m2.5612
14norartocarpetin2.4010
15hexylresorcinol2.4010
16l mimosine2.309
17morachalcone a2.208
18n trans feruloyldopamine2.087
1934 dihydroxyxanthone1.956
20arbutin1.795
21Phenylthiourea Phenylthiourea is1.614
22chrysin0.691
23Kaempferols0.691
24Luteolin 5,7,3',4'-tetrahydroxy-flavone,0.691
25Mimosine 3-Hydroxy-4-oxo-1(4H)-pyridinealanine.0.691

About TYR as a Drug Target

TYR (tyrosinase) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 25 compounds with documented TYR interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

TYR inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.